CURATIS.COM: Keyword Density Checker

Total words: 3186 | 2-word phrases: 822 | 3-word phrases: 942 | 4-word phrases: 991

PAGE INFO

Title	Try to keep the title under 60 characters (0 characters)
Description	Try to keep the meta description between 50 - 160 characters (31 characters) Innovative Specialist Medicines
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (13 characters) About Curatis

#	Keyword	Frequency	Density
1	member of the	10	1.06%
2	the university of	9	0.96%
3	of the board	9	0.96%
4	the board of	8	0.85%
5	from the university	7	0.74%
6	board of directors	6	0.64%
7	executive member of	5	0.53%
8	chief executive officer	4	0.42%
9	– next major	4	0.42%
10	vice presidentgeneral manager	3	0.32%
11	a member of	3	0.32%
12	holds a phd	3	0.32%
13	a phd in	3	0.32%
14	of the executive	3	0.32%
15	next major development	3	0.32%
16	spirig pharma ag	3	0.32%
17	board member of	3	0.32%
18	general manager at	3	0.32%
19	for the treatment	3	0.32%
20	previously he held	3	0.32%
21	myocontract now santhera	2	0.21%
22	pharmaceuticals hoffmannla roche	2	0.21%
23	contura myocontract now	2	0.21%
24	hoffmannla roche in	2	0.21%
25	european pharma now	2	0.21%
26	marketing europe at	2	0.21%
27	speciality european pharma	2	0.21%
28	management positions at	2	0.21%
29	commercial management positions	2	0.21%
30	held various commercial	2	0.21%

#	Keyword	Frequency	Density
1	from the university of	7	0.71%
2	of the board of	7	0.71%
3	member of the board	6	0.61%
4	the board of directors	6	0.61%
5	executive member of the	5	0.50%
6	– next major development	3	0.30%
7	member of the executive	3	0.30%
8	holds a phd in	3	0.30%
9	a member of the	3	0.30%
10	gÜnter graubach founderexecutive member	2	0.20%
11	as group general counsel	2	0.20%
12	management programs at insead	2	0.20%
13	and curatis’ chief executive	2	0.20%
14	and a member of	2	0.20%
15	nonexecutive member of the	2	0.20%
16	chief corporate development officer	2	0.20%
17	corporate development officer ccdo	2	0.20%
18	former chairman of the	2	0.20%
19	chairman of the board	2	0.20%
20	of directors of curatis	2	0.20%
21	directors of curatis 2012april	2	0.20%
22	of curatis 2012april 2024	2	0.20%
23	of basle and completed	2	0.20%
24	commercial management positions at	2	0.20%
25	officer until 2011 held	2	0.20%
26	the university of lyon	2	0.20%
27	20122019 previously he held	2	0.20%
28	spirig pharma ag he	2	0.20%
29	the university of constance	2	0.20%
30	for the treatment of	2	0.20%
31	international economic relations from	2	0.20%
32	and a “licoecint” in	2	0.20%
33	france and a “licoecint”	2	0.20%
34	next major development step	2	0.20%
35	sociale” from the university	2	0.20%
36	until 2011 held various	2	0.20%
37	graduated with a “maîtrise	2	0.20%
38	usa and latin america	2	0.20%
39	switzerland usa and latin	2	0.20%
40	step clinical phase iib	2	0.20%